PFSA MEXC RealStocks
Own real PFSA shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-16 00:07:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Profusa, Inc. (PFSA) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.44, with a market capitalization of $271.33K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.40 to $1,516.50. This page covers its latest market performance, valuation, price trends and company information.
$271.33K | |
$0.49 | |
$0.49 | |
$0.41 | |
$0.46 | |
387.93K | |
3.63M | |
-- | |
$1,516.50 | |
$0.40 | |
-- | |
-- |
Profusa, Inc. (PFSA) last closed at $0.44 as of 2026-11-14 00:59:00, down 10.87% ($0.05) from the previous close of $0.46.
During the latest regular trading session, PFSA traded between $0.41 and $0.49, with a volume of 387.93K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Profusa, Inc. (PFSA) moved from $0.57 to $0.44, representing a decline of 22.43% ($0.13).
The stock traded between $0.40 and $0.65 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 976.81 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.0%
PFSA is currently trading at $0.44, placing it 0.0% of the way from its 52-week low of $0.40 to its 52-week high of $1,516.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Profusa, Inc. (PFSA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PFSA, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between PFSA shares and USD.
PFSA Shares to USD
1.00 PFSA shares = 0.442 USD
Calculations are estimates based on the latest available price and are for reference only.